Performance Comparison of Recombinant Baculovirus and Rabies Virus-like Particles production Using Two Culture Platforms
This work aimed to assess, following upstream optimization in Schott flasks, the scalability from this culture platform to a stirred-tank bioreactor in order to yield rabies-recombinant baculovirus, bearing genes of G (BVG) and M (BVM) proteins, and to obtain rabies virus-like particles (VLP) from t...
Saved in:
Published in | Vaccines (Basel) Vol. 11; no. 1; p. 39 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
24.12.2022
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | This work aimed to assess, following upstream optimization in Schott flasks, the scalability from this culture platform to a stirred-tank bioreactor in order to yield rabies-recombinant baculovirus, bearing genes of G (BVG) and M (BVM) proteins, and to obtain rabies virus-like particles (VLP) from them, using Sf9 insect cells as a host. Equivalent assays in Schott flasks and a bioreactor were performed to compare both systems and a multivariate statistical approach was also carried out to maximize VLP production as a function of BVG and BVM's multiplicity of infection (MOI) and harvest time (HT). Viable cell density, cell viability, virus titer, BVG and BVM quantification by dot-blot, and BVG quantification by Enzyme-Linked Immunosorbent Assay (ELISA) were monitored throughout the assays. Furthermore, transmission electron microscopy was used to characterize rabies VLP. The optimal combination for maximum VLP expression was BVG and BVM MOI of 2.3 pfu/cell and 5.1 pfu/cell, respectively, and 108 h of harvest time. The current study confirmed that the utilization of Schott flasks and a benchtop bioreactor under the conditions applied herein are equivalent regarding the cell death kinetics corresponding to the recombinant baculovirus infection process in Sf9 cells. According to the results, the hydrodynamic and chemical differences in both systems seem to greatly affect the virus and VLP integrity after release. |
---|---|
AbstractList | This work aimed to assess, following upstream optimization in Schott flasks, the scalability from this culture platform to a stirred-tank bioreactor in order to yield rabies-recombinant baculovirus, bearing genes of G (BVG) and M (BVM) proteins, and to obtain rabies virus-like particles (VLP) from them, using Sf9 insect cells as a host. Equivalent assays in Schott flasks and a bioreactor were performed to compare both systems and a multivariate statistical approach was also carried out to maximize VLP production as a function of BVG and BVM’s multiplicity of infection (MOI) and harvest time (HT). Viable cell density, cell viability, virus titer, BVG and BVM quantification by dot-blot, and BVG quantification by Enzyme-Linked Immunosorbent Assay (ELISA) were monitored throughout the assays. Furthermore, transmission electron microscopy was used to characterize rabies VLP. The optimal combination for maximum VLP expression was BVG and BVM MOI of 2.3 pfu/cell and 5.1 pfu/cell, respectively, and 108 h of harvest time. The current study confirmed that the utilization of Schott flasks and a benchtop bioreactor under the conditions applied herein are equivalent regarding the cell death kinetics corresponding to the recombinant baculovirus infection process in Sf9 cells. According to the results, the hydrodynamic and chemical differences in both systems seem to greatly affect the virus and VLP integrity after release. |
Author | Guardalini, Luis Giovani Oliveira Jared, Simone Gonçalves Silva Tonso, Aldo Antoniazzi, Marta Maria Astray, Renato Mancini Fernández Núñez, Eutimio Gustavo Cavalcante, Paulo Eduardo da Silva Leme, Jaci Bernardino, Thaissa Consoni Mello, Renata Gois de Jorge, Soraia Attie Calil |
AuthorAffiliation | 2 Laboratório de Biologia Estrutural, Instituto Butantan, Av Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil 5 Grupo de Engenharia de Bioprocessos, Escola de Artes, Ciências e Humanidades (EACH), Universidade de São Paulo, Rua Arlindo Béttio, 1000, São Paulo CEP 03828-000, SP, Brazil 4 Laboratório de Células Animais, Departamento de Engenharia Química, Escola Politécnica, Universidade de São Paulo. Av. Prof. Luciano Gualberto, Trav. 3, 380, São Paulo CEP 05508-900, SP, Brazil 1 Laboratório de Biotecnologia Viral, Instituto Butantan, Av Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil 3 Laboratório Multipropósito, Instituto Butantan, Av. Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil |
AuthorAffiliation_xml | – name: 3 Laboratório Multipropósito, Instituto Butantan, Av. Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil – name: 4 Laboratório de Células Animais, Departamento de Engenharia Química, Escola Politécnica, Universidade de São Paulo. Av. Prof. Luciano Gualberto, Trav. 3, 380, São Paulo CEP 05508-900, SP, Brazil – name: 5 Grupo de Engenharia de Bioprocessos, Escola de Artes, Ciências e Humanidades (EACH), Universidade de São Paulo, Rua Arlindo Béttio, 1000, São Paulo CEP 03828-000, SP, Brazil – name: 1 Laboratório de Biotecnologia Viral, Instituto Butantan, Av Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil – name: 2 Laboratório de Biologia Estrutural, Instituto Butantan, Av Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil |
Author_xml | – sequence: 1 givenname: Luis Giovani Oliveira orcidid: 0000-0001-5143-7024 surname: Guardalini fullname: Guardalini, Luis Giovani Oliveira organization: Laboratório de Biotecnologia Viral, Instituto Butantan, Av Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil – sequence: 2 givenname: Paulo Eduardo da Silva surname: Cavalcante fullname: Cavalcante, Paulo Eduardo da Silva organization: Laboratório de Biotecnologia Viral, Instituto Butantan, Av Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil – sequence: 3 givenname: Jaci surname: Leme fullname: Leme, Jaci organization: Laboratório de Biotecnologia Viral, Instituto Butantan, Av Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil – sequence: 4 givenname: Renata Gois de surname: Mello fullname: Mello, Renata Gois de organization: Laboratório de Biotecnologia Viral, Instituto Butantan, Av Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil – sequence: 5 givenname: Thaissa Consoni surname: Bernardino fullname: Bernardino, Thaissa Consoni organization: Laboratório de Biotecnologia Viral, Instituto Butantan, Av Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil – sequence: 6 givenname: Simone Gonçalves Silva surname: Jared fullname: Jared, Simone Gonçalves Silva organization: Laboratório de Biologia Estrutural, Instituto Butantan, Av Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil – sequence: 7 givenname: Marta Maria surname: Antoniazzi fullname: Antoniazzi, Marta Maria organization: Laboratório de Biologia Estrutural, Instituto Butantan, Av Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil – sequence: 8 givenname: Renato Mancini orcidid: 0000-0002-6983-5298 surname: Astray fullname: Astray, Renato Mancini organization: Laboratório Multipropósito, Instituto Butantan, Av. Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil – sequence: 9 givenname: Aldo orcidid: 0000-0001-8498-7348 surname: Tonso fullname: Tonso, Aldo organization: Laboratório de Células Animais, Departamento de Engenharia Química, Escola Politécnica, Universidade de São Paulo. Av. Prof. Luciano Gualberto, Trav. 3, 380, São Paulo CEP 05508-900, SP, Brazil – sequence: 10 givenname: Eutimio Gustavo orcidid: 0000-0002-2800-392X surname: Fernández Núñez fullname: Fernández Núñez, Eutimio Gustavo organization: Grupo de Engenharia de Bioprocessos, Escola de Artes, Ciências e Humanidades (EACH), Universidade de São Paulo, Rua Arlindo Béttio, 1000, São Paulo CEP 03828-000, SP, Brazil – sequence: 11 givenname: Soraia Attie Calil surname: Jorge fullname: Jorge, Soraia Attie Calil organization: Laboratório de Biotecnologia Viral, Instituto Butantan, Av Vital Brasil 1500, São Paulo CEP 05503-900, SP, Brazil |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36679884$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkttvFCEUxompsbXtu0-GxBdfxnIbLi8muvHSpIlN0za-EWCYlXUGVphZ9b-XdbdNW14gh-_8zuHwvQQHMUUPwCuM3lGq0NnGOBeiLxgjjBBVz8ARQYI3VNHvBw_Oh-C0lBWqS2EquXgBDinnQknJjsCfS5_7lEcTnYeLNK5NDiVFmHp45V0abYgmTvCjcfOQNiHPBZrYwStjgy_wdhtohvDTw0uTp-CGGlzn1M1uCpVyU0JcwuvfCS7mYZpzlQ1m2tYrJ-B5b4biT_f7Mbj5_Ol68bW5-PblfPHhonFMoanpWyl57VSqjihhvFWWCOcI8aIVrmdYso5Z6RlR1mOJsGXSWO6k7JGRztJjcL7jdsms9DqH0eS_Opmg_wdSXup955qyHilBOHXIMmKUbDm2qseipRixTlXW-x1rPdvRd87HKZvhEfTxTQw_9DJttKpjx7itgLd7QE6_Zl8mPYbi_DCY6NNcNBFcEkqY5FX65ol0leYc66i2KkGkrB9YVWincjmVkn1_3wxGeusS_dQlNeX1w0fcJ9x5gv4Db2m9ig |
CitedBy_id | crossref_primary_10_1002_jctb_7571 crossref_primary_10_1016_j_bej_2023_109013 crossref_primary_10_1016_j_saa_2024_124638 crossref_primary_10_1007_s12033_023_00759_2 |
Cites_doi | 10.1080/14760584.2018.1516552 10.1038/s41598-020-57761-w 10.1007/s12033-021-00366-z 10.29245/2578-3009/2018/2.1118 10.1007/s00253-018-8962-0 10.2144/000113238 10.1016/j.jbiotec.2015.10.013 10.3390/pr8091179 10.1016/j.vaccine.2014.06.058 10.1007/BF00353943 10.1007/978-1-4939-3043-2_8 10.4149/av_2017_306 10.1007/978-1-4939-3387-7_7 10.1016/j.jbiotec.2012.05.016 10.1016/B978-0-12-801919-1.00005-1 10.1002/0471142735.ima03bs21 10.1002/bit.22192 10.1007/BF02521742 10.3390/v7031134 10.1007/s10616-008-9134-3 10.1099/jgv.0.001108 10.1080/00224065.1980.11980968 10.2807/1560-7917.ES.2020.25.38.2000158 10.1007/978-3-030-21084-7 10.1093/oxfordjournals.aje.a118408 10.1002/biot.200700179 |
ContentType | Journal Article |
Copyright | 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022 by the authors. 2022 |
Copyright_xml | – notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022 by the authors. 2022 |
DBID | NPM AAYXX CITATION 3V. 7T7 7XB 8FD 8FE 8FH 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FR3 GNUQQ GUQSH HCIFZ LK8 M2O M7P MBDVC P64 PIMPY PQEST PQQKQ PQUKI Q9U 7X8 5PM DOA |
DOI | 10.3390/vaccines11010039 |
DatabaseName | PubMed CrossRef ProQuest Central (Corporate) Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (purchase pre-March 2016) Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection AUTh Library subscriptions: ProQuest Central ProQuest Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Engineering Research Database ProQuest Central Student Research Library Prep SciTech Premium Collection (Proquest) (PQ_SDU_P3) Biological Sciences ProQuest research library Biological Science Database Research Library (Corporate) Biotechnology and BioEngineering Abstracts Access via ProQuest (Open Access) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef Publicly Available Content Database Research Library Prep ProQuest Central Student Technology Research Database ProQuest Central Essentials ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College Research Library (Alumni Edition) ProQuest Natural Science Collection Environmental Sciences and Pollution Management ProQuest Central Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Research Library Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition Biological Science Database ProQuest SciTech Collection Biotechnology and BioEngineering Abstracts ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef Publicly Available Content Database PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 2076-393X |
ExternalDocumentID | oai_doaj_org_article_34f097263c0b42a98561b9f1753104d9 10_3390_vaccines11010039 36679884 |
Genre | Journal Article |
GeographicLocations | United States--US New Jersey |
GeographicLocations_xml | – name: New Jersey – name: United States--US |
GrantInformation_xml | – fundername: Universidade de São Paulo grantid: AUXPE PROAP CAPES – fundername: National Council of Technological and Scientific Development (CNPq) grantid: 168539/2018-7 – fundername: University of São Paulo (USP) – fundername: São Paulo Research Foundation (FAPESP) grantid: 2018/10538-1; 2016/22780-6 |
GroupedDBID | 3V. 53G 5VS 8FE 8FH 8G5 AADQD AAHBH ABUWG ADBBV AFKRA AFZYC ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BBNVY BCNDV BENPR BHPHI BPHCQ CCPQU DIK DWQXO GNUQQ GROUPED_DOAJ GUQSH HCIFZ HYE IAO IHR ITC KQ8 LK8 M2O M48 M7P MODMG M~E NPM OK1 PGMZT PIMPY PQQKQ PROAC RIG RNS RPM AAYXX CITATION 7T7 7XB 8FD 8FK C1K FR3 MBDVC P64 PQEST PQUKI Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c490t-f588688489d297aeb9b27cc22e757cf4184d4b8e429be1801b48ab6c88f0a8cb3 |
IEDL.DBID | RPM |
ISSN | 2076-393X |
IngestDate | Tue Oct 22 15:04:34 EDT 2024 Tue Sep 17 21:30:31 EDT 2024 Fri Oct 25 05:04:30 EDT 2024 Sat Nov 09 13:25:47 EST 2024 Thu Sep 26 21:16:09 EDT 2024 Wed Oct 16 00:40:10 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | stirred-tank bioreactor quality by design viral infection rabies virus-like particles Sf9 cells recombinant baculovirus |
Language | English |
License | Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c490t-f588688489d297aeb9b27cc22e757cf4184d4b8e429be1801b48ab6c88f0a8cb3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-8498-7348 0000-0002-6983-5298 0000-0002-2800-392X 0000-0001-5143-7024 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867115/ |
PMID | 36679884 |
PQID | 2767288988 |
PQPubID | 2032320 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_34f097263c0b42a98561b9f1753104d9 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9867115 proquest_miscellaneous_2768232486 proquest_journals_2767288988 crossref_primary_10_3390_vaccines11010039 pubmed_primary_36679884 |
PublicationCentury | 2000 |
PublicationDate | 20221224 |
PublicationDateYYYYMMDD | 2022-12-24 |
PublicationDate_xml | – month: 12 year: 2022 text: 20221224 day: 24 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | Vaccines (Basel) |
PublicationTitleAlternate | Vaccines (Basel) |
PublicationYear | 2022 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | Hopkins (ref_14) 2009; 47 Rao (ref_21) 2008; 102 Donaldson (ref_6) 2018; 17 Decarli (ref_9) 2018; 102 Saxena (ref_24) 2018; 99 Fontana (ref_5) 2016; 1403 Chan (ref_22) 2016; 1350 ref_13 Katz (ref_1) 2017; 61 Power (ref_25) 1992; 9 Swiech (ref_10) 2008; 57 Reed (ref_17) 1938; 27 ref_16 Changalucha (ref_2) 2021; 16 Dietzschold (ref_27) 2015; 2 Koraka (ref_28) 2014; 32 Kang (ref_26) 2015; 7 Rossi (ref_11) 2012; 161 ref_20 Palomares (ref_8) 1996; 22 Gossner (ref_3) 2020; 25 Bernardino (ref_15) 2021; 63 Astray (ref_18) 2008; 3 Derringer (ref_19) 1980; 12 Strobl (ref_12) 2020; 10 Dubois (ref_23) 2015; 216 ref_4 Dai (ref_7) 2018; 2 |
References_xml | – volume: 17 start-page: 833 year: 2018 ident: ref_6 article-title: Virus-like particle vaccines: Immunology and formulation for clinical translation publication-title: Expert Rev. Vaccines doi: 10.1080/14760584.2018.1516552 contributor: fullname: Donaldson – volume: 10 start-page: 1 year: 2020 ident: ref_12 article-title: Evaluation of screening platforms for virus-like particle production with the baculovirus expression vector system in insect cells publication-title: Sci. Rep. doi: 10.1038/s41598-020-57761-w contributor: fullname: Strobl – volume: 63 start-page: 1068 year: 2021 ident: ref_15 article-title: Production of Rabies VLPs in Insect Cells by Two Monocistronic Baculoviruses Approach publication-title: Mol. Biotechnol. doi: 10.1007/s12033-021-00366-z contributor: fullname: Bernardino – volume: 16 start-page: 39 year: 2021 ident: ref_2 article-title: Human rabies: Prospects for elimination publication-title: CAB Rev. Perspect. Agric. Veter- Sci. Nutr. Nat. Resour. contributor: fullname: Changalucha – volume: 2 start-page: 36 year: 2018 ident: ref_7 article-title: Advances and challenges in enveloped virus-like particle (VLP)-based vaccines publication-title: J. Immunol. Sci. doi: 10.29245/2578-3009/2018/2.1118 contributor: fullname: Dai – volume: 102 start-page: 4773 year: 2018 ident: ref_9 article-title: DROSOPHILA S2 cell culture in a WAVE Bioreactor: Potential for scaling up the production of the recombinant rabies virus glycoprotein publication-title: Appl. Microbiol. Biotechnol. doi: 10.1007/s00253-018-8962-0 contributor: fullname: Decarli – volume: 47 start-page: 785 year: 2009 ident: ref_14 article-title: A rapid method for titrating baculovirus stocks using the Sf-9 Easy Titer cell line publication-title: Biotechniques doi: 10.2144/000113238 contributor: fullname: Hopkins – volume: 216 start-page: 110 year: 2015 ident: ref_23 article-title: Insect cell entrapment, growth and recovering using a single-use fixed-bed bioreactor. Scaling up and recombinant protein production publication-title: J. Biotechnol. doi: 10.1016/j.jbiotec.2015.10.013 contributor: fullname: Dubois – ident: ref_20 doi: 10.3390/pr8091179 – volume: 32 start-page: 4644 year: 2014 ident: ref_28 article-title: A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice publication-title: Vaccine doi: 10.1016/j.vaccine.2014.06.058 contributor: fullname: Koraka – volume: 22 start-page: 225 year: 1996 ident: ref_8 article-title: The effect of dissolved oxygen tension and the utility of oxygen uptake rate in insect cell culture publication-title: Cytotechnology doi: 10.1007/BF00353943 contributor: fullname: Palomares – volume: 1350 start-page: 161 year: 2016 ident: ref_22 article-title: Development of Serum-Free Media for Lepidopteran Insect Cell Lines publication-title: Baculovirus and Insect Cell Expression Protocols doi: 10.1007/978-1-4939-3043-2_8 contributor: fullname: Chan – volume: 61 start-page: 280 year: 2017 ident: ref_1 article-title: Large protein as a potential target for use in rabies diagnostics publication-title: Acta Virol. doi: 10.4149/av_2017_306 contributor: fullname: Katz – volume: 1403 start-page: 155 year: 2016 ident: ref_5 article-title: Development of Rabies Virus-Like Particles for Vaccine Applications: Production, Characterization, and Protection Studies publication-title: Vaccine Design doi: 10.1007/978-1-4939-3387-7_7 contributor: fullname: Fontana – volume: 161 start-page: 328 year: 2012 ident: ref_11 article-title: Effect of hypothermic temperatures on production of rabies virus glycoprotein by recombinant Drosophila melanogaster S2 cells cultured in suspension publication-title: J. Biotechnol. doi: 10.1016/j.jbiotec.2012.05.016 contributor: fullname: Rossi – volume: 2 start-page: 47 year: 2015 ident: ref_27 article-title: Purification of Rabies Virus and Its Subunits publication-title: Current Laboratory Techniques in Rabies Diagnosis, Research and Prevention doi: 10.1016/B978-0-12-801919-1.00005-1 contributor: fullname: Dietzschold – ident: ref_16 doi: 10.1002/0471142735.ima03bs21 – volume: 102 start-page: 348 year: 2008 ident: ref_21 article-title: Disposable bioprocessing: The future has arrived publication-title: Biotechnol. Bioeng. doi: 10.1002/bit.22192 contributor: fullname: Rao – volume: 9 start-page: 149 year: 1992 ident: ref_25 article-title: Modelling the growth and protein production by insect cells following infection by a recombinant baculovirus in suspension culture publication-title: Cytotechnology doi: 10.1007/BF02521742 contributor: fullname: Power – volume: 7 start-page: 1134 year: 2015 ident: ref_26 article-title: Chimeric Rabies Virus-Like Particles Containing Membrane-Anchored GM-CSF Enhances the Immune Response against Rabies Virus publication-title: Viruses doi: 10.3390/v7031134 contributor: fullname: Kang – volume: 57 start-page: 67 year: 2008 ident: ref_10 article-title: Enhanced production of recombinant rabies virus glycoprotein (rRVGP) by Drosophila melanogaster S2 cells through control of culture conditions publication-title: Cytotechnology doi: 10.1007/s10616-008-9134-3 contributor: fullname: Swiech – volume: 99 start-page: 1151 year: 2018 ident: ref_24 article-title: A structured review of baculovirus infection process: Integration of mathematical models and biomolecular information on cell–virus interaction publication-title: J. Gen. Virol. doi: 10.1099/jgv.0.001108 contributor: fullname: Saxena – volume: 12 start-page: 214 year: 1980 ident: ref_19 article-title: Simultaneous Optimization of Several Response Variables publication-title: J. Qual. Technol. doi: 10.1080/00224065.1980.11980968 contributor: fullname: Derringer – ident: ref_13 – volume: 25 start-page: 2000158 year: 2020 ident: ref_3 article-title: Prevention of human rabies: A challenge for the European Union and the European Economic Area publication-title: Eurosurveillance doi: 10.2807/1560-7917.ES.2020.25.38.2000158 contributor: fullname: Gossner – ident: ref_4 doi: 10.1007/978-3-030-21084-7 – volume: 27 start-page: 493 year: 1938 ident: ref_17 article-title: A simple method of estimating fifty per cent endpoints publication-title: Am. J. Epidemiol. doi: 10.1093/oxfordjournals.aje.a118408 contributor: fullname: Reed – volume: 3 start-page: 98 year: 2008 ident: ref_18 article-title: Analytical approach for the extraction of recombinant membrane viral glycoprotein from stably transfected Drosophila melanogaster cells publication-title: Biotechnol. J. doi: 10.1002/biot.200700179 contributor: fullname: Astray |
SSID | ssj0000913867 |
Score | 2.2971668 |
Snippet | This work aimed to assess, following upstream optimization in Schott flasks, the scalability from this culture platform to a stirred-tank bioreactor in order... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 39 |
SubjectTerms | Assaying Baculovirus Bioreactors Cell culture Cell death Cell density Cell viability Design of experiments Disease prevention Enzyme-linked immunosorbent assay Equivalence Flasks Hepatitis Infections Insect cells Insects Multiplicity of infection Optimization Proteins quality by design Rabies rabies virus-like particles recombinant baculovirus RNA polymerase Sf9 cells stirred-tank bioreactor Transmission electron microscopy Vaccines viral infection Virus-like particles Viruses |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlp1xK33WbFBVKoBCTtayVRsckJIRCy1I2JTcjyRJdurVDvJsm_z4z1j5DoZde9cCSZuSZj5n5xNinYMAFY3zuKfFJRhVya03MtZPCS3Q4Qk_2_PWburiUX66GVxtPfVFOWKIHTgd3VMpIDDOq9AOcbg2gwXcmEsEkIok6le4NzAaY6v_BpihB6RSXLBHXH91aT5HqDs1dQQWpW3aop-v_m4_5OFVyw_acP2NPF04jP06Lfc6ehOYFOxgl1un7Qz5eF1F1h_yAj9Z81Pcv2d1oXRzAT1fvDvI2cgKfv12fDMNPrJ9P29vJzbzjtqn5d-sQRfMf1JBPJ78CHy2z6Ph14olFmfI-54CP_7Q8sXPisKmd0fe6V-zy_Gx8epEvHlzIUSyDWR6HAApAgqmF0TY444T2Xoigh9pHiWiwlg4C2jAXCrRtToJ1ygPEgQXvytdsp2mb8JYypiCicxadr400tbJKRgPChaADhWYz9nl5_NV14tWoEI-QqKrHosrYCclnNY4YsfsG1JNqsfPqX3qSsb2ldKvFNe0qoZUWAAYgYx9X3XjBKGpim9DO-zFAbieojL1JyrBaSakoiEW70VtqsrXU7Z5m8rMn8TZELFgM3_2Pvb1nu4KqMgqRC7nHdmY387CPvtLMfeivxQNZVRTK priority: 102 providerName: Directory of Open Access Journals – databaseName: AUTh Library subscriptions: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELege-EF8U1hICOhSUiL1jqufX5CdNo0ITFVU4f2FtmOzSpKUpp2sP-euyRN6YR4ta3E9p19d7673zH2PhhwwRifeAp8klGFxFoTE-2k8BIVjlCDPX85V2eX8vPV6Kp9cKvasMrNnVhf1Hnp6Y38SGilBYAB-Lj4mVDVKPKutiU07rM9gZbCoMf2xifnk4vulYVQL0Hpxj-Zon1_dGM9eawrFHtDSkzdkUc1bP-_dM27IZN_yaDTR-xhqzzyTw21H7N7oXjCDiYN-vTtIZ9uk6mqQ37AJ1tc6tun7PdkmyTAj7v6g7yMnIzQH64OiuFj69fz8ma2XFfcFjm_sA6taf6VGpL57Hvgk000HV80eLFIW17HHvDpr5I3KJ04bG5X9L_qGbs8PZkenyVt4YUEyTNYJXEEoAAkmFwYbYMzTmjvhQh6pH2UaBXm0kFAWebCEGWck2Cd8gBxYMG79DnrFWURXlLkFERU0qLzuZEmV1bJaEC4EHQgF22ffdhsf7Zo8DUytEuIVNldUvXZmOjTjSNk7LqhXH7L2pVnqYyESKRSP0B2swZQQXQmEiApWp45fmR_Q92sPa5VtmWuPnvXdeNBI--JLUK5rscAqZ-g-uxFwwzdTFJFzixajd5hk52p7vYUs-sazNsQwOBw9Or_03rNHgjKuxiKRMh91lst1-ENakMr97Zl-T9CjA-U priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dixMxEA96vvgifls9JYIcCLfazabZyYOId3gcglKklb4tSTbRYt09u-15_e-dyW5be_TB103I10x25sfM_MLYK6_Beq1d4ijxSQblE2N0SHIrhZPocPhI9vz5izofy0-TwWRbHt0dYLMX2tF7UuP57M3V79V7vPDvCHEiZH97aRwFoRu0ZCnVmt5kt4REnE6JfJ2zH__LOs0gPikrELwnmc4mbdxy7yA7dirS-e_zQa-nUv5jm87usjudU8k_tFpwj93w1X12NGxZqVfHfLQtsmqO-REfbvmqVw_Y1XBbPMBPN-8S8jpwAqe_bEyW4SfGLWf15XS-bLipSv7VWETZ_Bt9SGbTn54P11l2_KLlkUWZ85iTwEd_at6yd2K3mVnQfM1DNj77ODo9T7oHGRIUW3-RhAGAApCgS6Fz4622IndOCJ8PchckosVSWvBo46xP0fZZCcYqBxD6BpzNHrGDqq78E8qogoDOW7Cu1FKXyigZNAjrfe4pdNtjr9fHX1y0vBsF4hUSVXFdVD12QvLZ9CPG7Pihnn8vup0XmQzEVKQy10c1NBrQcbQ6EFEpItISBzlcS7dYa2EhcpULAA3QYy83zXgBKapiKl8vYx8gtxRUjz1ulWGzkkxRkIt2k--oyc5Sd1uq6Y9I8q2JeDAdPP2PeZ-x24KKMlKRCHnIDhbzpX-OrtLCvog34C87uhZZ priority: 102 providerName: Scholars Portal |
Title | Performance Comparison of Recombinant Baculovirus and Rabies Virus-like Particles production Using Two Culture Platforms |
URI | https://www.ncbi.nlm.nih.gov/pubmed/36679884 https://www.proquest.com/docview/2767288988 https://search.proquest.com/docview/2768232486 https://pubmed.ncbi.nlm.nih.gov/PMC9867115 https://doaj.org/article/34f097263c0b42a98561b9f1753104d9 |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdtB6MvY9_z1gUNRmFQN7Esy9LjElrKIMWUdPTNSLK0hSV2iJN-_Pc7yXbSlD3txQ-WbMu6k-_O97ufEPpqBFdGCB1qB3yilplQSmHDVFGiKTgcxpM9jy_ZxTX9cZPc7KGkq4XxoH2tpqflbH5aTn97bOVirvsdTqyfjUfCkbJFSX8f7YOCPgrR_edXRDG0NynJGEL6_q3ULkldg6WLXC3qIXoeM5d94HTHGnnS_n95mk8Bk48s0PlL9KJ1HfH3Zoiv0J4pX6PjrOGefjjBk20pVX2Cj3G2ZaV-eIPus22JAB5tdh_ElcUuBJ0rD4nBQ6nXs-p2ulzXWJYFvpIKYmn8050IZ9M_BmfdHOFFwxYLksUeeYAndxVuODqh20yu3PPqt-j6_GwyugjbbRdCEM5gFdqEcwZzw0VBRCqNEoqkWhNi0iTVlkJMWFDFDVgyZSKwcIpyqZjm3A4k1yp-hw7KqjQfHG6KW3DRrNKFoKJgklErOFHGpMYlaAP0rZv-fNGwa-QQlTip5U-lFqChk8-mn-PF9ieq5a-8ffM8ptbxEbFYD0DZpODgHiphHR0pxJ0F3OSok27eLtY6JylLCeegDwH6smmGZeZyJ7I01dr34c755CxA7xtl2IykU6YApTtqsjPU3RbQbE_l3Wryx_--8hM6JK4gIyIhoUfoYLVcm8_gJq1UDz0bnl1mVz3_mwGOY8p7fqn8BTcfGoU |
link.rule.ids | 230,315,730,783,787,867,888,2109,2228,21400,24330,27936,27937,33756,33757,43817,53804,53806,74630 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdge4AXNL7LBhgJTUJatNZx7fMTotOmAlsVTR3aW2Q7NqtWktK0g_33-JI0pRPi1bYS23f23fnufkfIe6fAOKVsZDHwiXvhIq2Vj6ThzPKgcLgK7PlsJIYX_Mtl_7J5cCubsMrVnVhd1Flh8Y38kEkhGYAC-Dj7GWHVKPSuNiU07pNthKoKxtf24HiUnLevLIh6CULW_sk42PeHN9qix7oMYq-Hiakb8qiC7f-Xrnk3ZPIvGXSyQx41yiP9VFP7Mbnn8idkP6nRp28P6HidTFUe0H2arHGpb5-S38k6SYAetfUHaeEpGqE_TBUUQwfaLqfFzWS-LKnOM3quTbCm6TdsiKaTa0eTVTQdndV4sYG2tIo9oONfBa1ROsOwqV7g_8pn5OLkeHw0jJrCC1EgT3cR-T6AAOCgMqakdkYZJq1lzMm-tJ4HqzDjBlyQZcb1gowzHLQRFsB3NVgTPydbeZG7lxg5BT4oad7YTHGVCS24V8CMc9Khi7ZDPqy2P53V-BppsEuQVOldUnXIAOnTjkNk7KqhmH9Pm5WnMfeISCRi2w3sphUEBdEoj4CkwfLMwkf2VtRNm-Napmvm6pB3bXc4aOg90bkrltUYQPUTRIe8qJmhnUks0JmFq5EbbLIx1c2efHJVgXkrBBjs9V_9f1pvyYPh-Ow0Pf08-rpLHjLMweixiPE9srWYL93roBktzJuG_f8ATXgSjg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELegkxAviO91DDASmoS0aK3j-uMJ0bFqfFXR1KG9RbZjQ0WXlKYd7L_nLklTOiFebStxcmffne93PxPy2mtlvdYucgh84kH4yBgdImk5cxwcDl-RPX8Zi9Nz_vFicNHgn8oGVrneE6uNOiscnpEfMSkkU0pDwBYaWETyfvR2_jPCG6Qw09pcp3Gb7Egu4l6H7AxPxslZe-KCDJhKyDpXGUOsf3RlHGavSzCBfSxS3bJNFYX_v_zOm_DJv-zR6D651ziS9F0t-Qfkls8fkoOkZqK-PqSTTWFVeUgPaLLhqL5-RH4nm4IBetzeRUiLQDEgvbQVQIYOjVvNiqvpYlVSk2f0zFiIrOlXbIhm0x-eJmtkHZ3X3LEgZ1rhEOjkV0Frxk4YNjNLfF_5mJyPTibHp1FzCUMEouotozBQSijFlc6YlsZbbZl0jjEvB9IFDhFixq3yYNes74O9s1wZK5xSoWeUs_ET0smL3O8iikoFcNiCdZnmOhNG8KAVs95Lj-naLnmz_v3pvObaSCFGQVGlN0XVJUOUTzsOWbKrhmLxLW2-PI15QHYiEbseqJ7RCpxFqwOSk0IUmsFD9tfSTZulW6YbReuSV203LDrMpJjcF6tqjEJXVIkueVorQzuTWGBiC79GbqnJ1lS3e_Lp94rYWyPZYH-w9_9pvSR3QPPTzx_Gn56RuwzLMfosYnyfdJaLlX8OTtLSvmi0_w_XvRa8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Performance+Comparison+of+Recombinant+Baculovirus+and+Rabies+Virus-like+Particles+production+Using+Two+Culture+Platforms&rft.jtitle=Vaccines+%28Basel%29&rft.au=Guardalini%2C+Luis+Giovani+Oliveira&rft.au=Cavalcante%2C+Paulo+Eduardo+da+Silva&rft.au=Leme%2C+Jaci&rft.au=Mello%2C+Renata+Gois+de&rft.date=2022-12-24&rft.issn=2076-393X&rft.eissn=2076-393X&rft.volume=11&rft.issue=1&rft_id=info:doi/10.3390%2Fvaccines11010039&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2076-393X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2076-393X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2076-393X&client=summon |